Ropivacaine injection
HSC20190878H
Phase 2 small_molecule active
Quick answer
Ropivacaine injection for Stress Disorders, Post-Traumatic is a Phase 2 program (small_molecule) at United Therapeutics Europe Ltd with 2 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Stress Disorders, Post-Traumatic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active